Caris Life Sciences (CAI) Retained Earnings (2024 - 2026)

Caris Life Sciences' Retained Earnings history runs 3 years deep, the most recent figure standing at $893000.0 for Q1 2026.

• In Q1 2026, Retained Earnings changed N/A year-over-year to $893000.0; the TTM figure through Mar 2026 stood at $893000.0 (changed N/A YoY), while the FY2025 annual figure was $936000.0, up 100.04% from the prior year.
• Retained Earnings was $893000.0 for Q1 2026 at Caris Life Sciences, down from $936000.0 in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $936000.0 in Q4 2025 to a low of -$2.5 billion in Q4 2024.
• Historically, Retained Earnings has averaged -$493.8 million across 3 years, with a median of $748000.0 in 2025.
• Biggest YoY gain for Retained Earnings was 100.04% in 2025; the steepest drop was 100.04% in 2025.
• A 3-year view of Retained Earnings shows it stood at -$2.5 billion in 2024, then surged by 100.04% to $936000.0 in 2025, then declined by 4.59% to $893000.0 in 2026.
• The last three Retained Earnings figures came in at $893000.0 (Q1 2026), $936000.0 (Q4 2025), and $748000.0 (Q3 2025), per Business Quant data.